|
Volumn 12, Issue 8, 2006, Pages 873-
|
Efomycine M: An inhibitor of selectins? [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARCINOEMBRYONIC ANTIGEN;
EFOMYCINE M;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
L SELECTIN;
PADGEM PROTEIN;
SELECTIN;
SELECTIN ANTAGONIST;
TRITIUM;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANTIINFLAMMATORY ACTIVITY;
CONCENTRATION RESPONSE;
CRYSTAL STRUCTURE;
CYTOKINE RELEASE;
DRUG CONFORMATION;
DRUG EFFECT;
DRUG MECHANISM;
DRUG PROTEIN BINDING;
HUMAN;
IC 50;
INFLAMMATION;
LETTER;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
APOPTOSIS;
B-LYMPHOCYTES;
BINDING SITES;
CELL SURVIVAL;
CELLS, CULTURED;
DENDRITIC CELLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIUM, VASCULAR;
HUMANS;
IMMUNOGLOBULINS;
INHIBITORY CONCENTRATION 50;
LEUKOCYTES, MONONUCLEAR;
LYMPHOCYTE ACTIVATION;
MACROLIDES;
MICE;
NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;
PROTEIN BINDING;
PROTEIN CONFORMATION;
RECOMBINANT FUSION PROTEINS;
SELECTINS;
STREPTOMYCES;
T-LYMPHOCYTES;
|
EID: 33746853387
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0806-873a Document Type: Letter |
Times cited : (9)
|
References (4)
|